What does Regencell Bioscience Holdings Ltd do?

Regencell Bioscience Holdings Ltd is a public company in the Medicinal Chemicals & Botanical Products industry, incorporated in E9. It is registered with the SEC under CIK 0001829667 and trades on NASDAQ under the ticker RGC.

How many SEC filings has Regencell Bioscience Holdings Ltd made?

Regencell Bioscience Holdings Ltd has filed 72 documents with the SEC since 2020. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

Regencell Bioscience Holdings Ltd

RGC NASDAQ CIK: 0001829667 Medicinal Chemicals & Botanical Products Inc. in E9

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 72 filings →

Form	Description	Date
3	—	Mar 18, 2026
3	—	Mar 18, 2026
3	—	Mar 18, 2026
3	—	Mar 18, 2026
3	—	Mar 18, 2026
3	—	Mar 18, 2026
3	—	Mar 18, 2026
6-K	REPORT OF FOREIGN PRIVATE ISSUER	Feb 13, 2026
20-F	ANNUAL REPORT	Oct 31, 2025
SCHEDULE 13D/A	—	Jul 11, 2025

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for Regencell Bioscience Holdings Ltd. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Financial data not yet loaded.

Details

CIK: 0001829667
Ticker: RGC
Exchange: NASDAQ
Incorporated: E9
First Filing: 2020
Total Filings: 72

Medicinal Chemicals & Botanical Products rankings →